How Important is it to Screen for Heart Disease

Less publicized than many other diseases, heart disease is the largest cause of death in the United States. A greater number of people lose their lives every year to heart disease than cancer, stroke, and car accidents. The number of those suffering from heart disease is actually greater than COVID-19 was in 2019, but all without the large response to the disease that has been at an epidemic scale.

COVID-19 killed 500,000 in 2019, Heart Disease killed 700,000 in 2022.
Cancer killed 500,000 in 2022, and Drug Over-Doses killed 110,000 in 2022.

Causing Heart Disease are factors like nutrition, genetics, physical activity, and drug use. Many other diseases such as diabetes and depression are even causes of heart disease. Diabetes, when not managed completely, causes damage to blood vessel walls that can allow the build-up of cholesterol, eventually causing stroke, heart attack, or coronary artery disease. Depression and stress can cause a release of Cortisol in the blood stream, the human stress hormone that, if produced in the body for a long enough time, can weaken blood vessels and cause heart attacks.

Because of the danger to humanity that is Heart Disease, its causes and risk factors, the U.S. Government has made ECG Testing the most reimbursed diagnostic test in the medical field. The screening for this disease is so important, because the disease kills as many as COVID-19 did at its peak, every single year.

ECG Testing produces a graph of a patient’s heart rhythm, a graph that is study-able and allows for the visual identification of heart disease and early signs of heart disease. Today’s ECG technology is intelligent enough to highlight sections of heart rhythm that computers identify as a sign of heart disease. This feature and more allow doctors to more easily detect heart disease, and to not only treat heart disease, but enable the prevention of heart disease.

Nasiff Associates, Inc. is the first company to develop an auto-diagnostic computer ECG System. Located in the United States, including Human Support for their systems, Nasiff has led the development of Cardio-Diagnostic Technologies for over 40 years.

With more detection features for both screening and research purposes, the Nasiff CardioCard ECG System has been popular among many of the best names in the Medical Diagnostic Industry.

Learn more about Nasiff Technologies and the reimbursement of ECG Testing at NASIFF.COM